Delivery Order SPE2DR25D1002-SPE2DR26FGN2V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,194.29 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 28, 2026, with completion targeted for January 29, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $28.6K to Amerisourcebergen Drug Corp for the supply of Vemlidy 25mg tablets (30-count) with a firm fixed-price structure. The award, issued on January 14, 2026, is scheduled for completion by February 11, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitive, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $12,049.24. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,126.96 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,316.31 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.59 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 master contract vehicle designed to supply pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $25,330.47 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,670.65 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by January 15, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,693.37 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-set-aside, firm fixed-price delivery order was awarded competitively and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGN2VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,954.23 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit packages) on January 27, 2026, with completion expected by January 28, 2026. This non-competitive, firm fixed-price delivery order was fulfilled from the company's place of performance in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle established to provide comprehensive pharmaceutical and medical supply support to military healthcare systems globally through December 2031. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare programs. The delivery order for Vemlidy, an antiviral medication, exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support federal medical institutions. As a major pharmaceutical distributor registered in the System for Award Management, AmerisourceBergen competes on a full and open basis for federal contracts and maintains significant capacity to fulfill government medical supply requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 1/26/26 |